Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc.

NNYSE:GRDN
49.43
USD
-0.09
(-0.18%)
1.19EPS
34.62P/E
2.58BMarket Cap
Mar 31Next Earn

Total Valuation

USD

As of September 30, 2026, Guardian Pharmacy Services, Inc. carries a market capitalization of 2.58B, placing it among publicly traded companies globally. Its enterprise value stands at 2.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.58B
Enterprise Value2.51B

Important Dates

Guardian Pharmacy Services, Inc.'s next confirmed earnings release is scheduled for March 31, 2027.

Earnings Date3/31/2027

Share Statistics

As of September 30, 2026, Guardian Pharmacy Services, Inc. has 63.34M shares outstanding.

Shares Outstanding63.34M

Valuation Ratios

As of September 30, 2026, Guardian Pharmacy Services, Inc. trades at a trailing price-to-earnings ratio of 34.62. The price-to-sales ratio is 1.78, and the price-to-book ratio stands at 9.67.

PE Ratio34.62
PS Ratio1.78
PB Ratio9.67
P/TBV Ratio15.71
P/FCF Ratio27.04
P/OCF Ratio22.69

Enterprise Valuation

As of September 30, 2026, Guardian Pharmacy Services, Inc. trades at an EV/EBITDA multiple of 21.36 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.72 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.68 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Guardian Pharmacy Services, Inc. trades at an EV/FCF ratio of 25.99, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 2.51B versus a market cap of 2.58B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.72
EV / EBITDA21.36
EV / EBIT26.68
EV / FCF25.99

Financial Position

As of September 30, 2026, Guardian Pharmacy Services, Inc. maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.72, indicating elevated leverage, while an interest coverage ratio of 181.48 demonstrates strong ability to service its debt obligations.

Current Ratio1.65
Quick Ratio1.27
Debt / Equity12.72
Debt / EBITDA0.30
Interest Coverage181.48

Financial Efficiency

USD

Over the twelve months ended September 30, 2026, Guardian Pharmacy Services, Inc. posted a return on equity (ROE) of 33.16, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 24.99 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 16.96, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 27.15, useful for judging operating efficiency across full business cycles. The company generates approximately 404,735.83 in revenue per employee across its workforce of 3,600.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 21.54 indicates how many times Guardian Pharmacy Services, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)33.16
Return on Assets (ROA)16.96
Return on Invested Capital (ROIC)24.99
Return on Capital Employed (ROCE)27.15
Revenue Per Employee404,735.83
Employee Count3,600.00
Inventory Turnover21.54

Taxes

USD

Over the twelve months ended September 30, 2026, Guardian Pharmacy Services, Inc. recorded 29.11M in income tax expense. That works out to an effective tax rate of 27.68, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 105.16M, leaving 74.77M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax29.11M
Effective Tax Rate27.68

Stock Price Statistics

USD

As of the close on November 16, 2026, Guardian Pharmacy Services, Inc.'s stock has gained approximately 69.22% over the past 52 weeks. The 50-day moving average sits at 42.65, while the 200-day moving average is 38.95.

52-Week Price Change69.22%
50-Day Moving Average42.65
200-Day Moving Average38.95

Income Statement

USD

Over the twelve months ended September 30, 2026, Guardian Pharmacy Services, Inc. generated 1.46B in revenue and converted that into 74.77M in net income, yielding earnings per share of 1.19. EBITDA reached 117.60M, while operating income came in at 94.14M.

Revenue1.46B
Gross Profit327.08M
Operating Income94.14M
Pretax Income105.16M
Net Income74.77M
EBITDA117.60M
EBIT94.14M
Earnings Per Share (EPS)1.19

Balance Sheet

USD

As of September 30, 2026, Guardian Pharmacy Services, Inc. holds 119.66M in cash and equivalents against 35.59M in total debt, resulting in a net debt position of -119.65M. Total book value stands at 267.24M, with working capital of 115.73M providing operational flexibility.

Cash & Cash Equivalents119.66M
Total Debt35.59M
Net Debt-119.65M
Equity (Book Value)267.24M
Book Value Per Share4.22
Working Capital115.73M

Cash Flow

USD

Guardian Pharmacy Services, Inc. produced 114.06M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -17.89M in capital expenditures, free cash flow totaled 96.17M - equivalent to 1.52 per share.

Operating Cash Flow114.06M
Capital Expenditures-17.89M
Free Cash Flow96.17M
FCF Per Share1.52

Margins

Over the twelve months ended September 30, 2026, Guardian Pharmacy Services, Inc. posted a gross margin of 22.45, reflecting its pricing power and cost economics. The operating margin of 6.46 and net profit margin of 5.13 provide insight into operational efficiency.

Gross Margin22.45
Operating Margin6.46
Pretax Margin7.22
Profit Margin5.13
EBITDA Margin8.07

Dividends & Yields

Over the twelve months ended September 30, 2026, Guardian Pharmacy Services, Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 3.70, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.24, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Guardian Pharmacy Services, Inc. shareholders.

Shareholder Yield0.24
FCF Yield3.70

Scores

As of September 30, 2026, Guardian Pharmacy Services, Inc. has an Altman Z-Score of 12.64, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score12.64